Cargando…
Effects of phenylcapsaicin on aerobic capacity and physiological parameters in active young males: a randomized, triple-blinded, placebo-controlled, crossover trial
Objective: Phenylcapsaicin (PC) is a new capsaicin analog which has exhibited a higher bioavailability. This sudy assessed the effects of a low dose (LD) of 0.625 mg and a high dose (HD) of 2.5 mg of PC on aerobic capacity, substrate oxidation, energy metabolism and exercise physiological variables...
Autores principales: | Jiménez-Martínez, Pablo, Alix-Fages, Carlos, Janicijevic, Danica, Miras-Moreno, Sergio, Chacón-Ventura, Sara, Martín-Olmedo, Juan J., De La Cruz-Márquez, Juan Carlos, Osuna-Prieto, Francisco J., Jurado-Fasoli, Lucas, Amaro-Gahete, Francisco J., García-Ramos, Amador, Colado, Juan C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203624/ https://www.ncbi.nlm.nih.gov/pubmed/37228817 http://dx.doi.org/10.3389/fphys.2023.1190345 |
Ejemplares similares
-
Effects of different phenylcapsaicin doses on neuromuscular activity and mechanical performance in trained male subjects: a randomized, triple-blinded, crossover, placebo-controlled trial
por: Jiménez-Martínez, Pablo, et al.
Publicado: (2023) -
Effects of different phenylcapsaicin doses on resistance training performance, muscle damage, protein breakdown, metabolic response, ratings of perceived exertion, and recovery: a randomized, triple-blinded, placebo-controlled, crossover trial
por: Jiménez-Martínez, Pablo, et al.
Publicado: (2023) -
Dietary Inflammatory Index and S-Klotho Plasma Levels in Middle-Aged Adults
por: Jurado-Fasoli, Lucas, et al.
Publicado: (2020) -
Caffeine increases maximal fat oxidation during a graded exercise test: is there a diurnal variation?
por: Ramírez-Maldonado, Mauricio, et al.
Publicado: (2021) -
Dihydrocapsiate does not increase energy expenditure nor fat oxidation during aerobic exercise in men with overweight/obesity: a randomized, triple-blinded, placebo-controlled, crossover trial
por: Osuna-Prieto, Francisco J., et al.
Publicado: (2022)